Abrams Capital Management LP Has Trimmed Its Teva Pharmaceutical Inds LTD (TEVA) Position by $7.14 Million; As Costar Group (CSGP) Share Value Rose, Wildcat Capital Management Has Cut by $1.14 Million Its Stake

Teva Pharmaceutical Industries Limited (NYSE:TEVA) Logo

Wildcat Capital Management Llc decreased its stake in Costar Group Inc (CSGP) by 1.8% based on its latest 2019Q1 regulatory filing with the SEC. Wildcat Capital Management Llc sold 2,450 shares as the company’s stock rose 24.07% . The institutional investor held 133,472 shares of the miscellaneous company at the end of 2019Q1, valued at $62.25M, down from 135,922 at the end of the previous reported quarter. Wildcat Capital Management Llc who had been investing in Costar Group Inc for a number of months, seems to be less bullish one the $23.16 billion market cap company. The stock increased 0.77% or $4.82 during the last trading session, reaching $633.74. About 289,615 shares traded or 12.26% up from the average. CoStar Group, Inc. (NASDAQ:CSGP) has risen 48.45% since August 11, 2018 and is uptrending. It has outperformed by 48.45% the S&P500. Some Historical CSGP News: 23/04/2018 - CoStar Group Sees 2Q Adj EPS $1.25-Adj EPS $1.34; 22/05/2018 - The Mogharebi Group Named as 2017 CoStar Power Broker Award Winners; 23/04/2018 - CoStar Group Sees 2Q Rev $292M-$295M; 23/04/2018 - COSTAR 1Q ADJ EPS $1.65, EST. $1.37; 25/04/2018 - Pioneer Select Mid Cap Growth Adds Microchip, Cuts CoStar; 24/05/2018 - CoStar Group: CoStar Exclusive: Madison Marquette, PMRG Merging; 16/03/2018 Garry Marr: Sources telling CoStar News that TTC has signed a major lease to consolidate its warehouse operations in NW Toronto; 23/04/2018 - CoStar Group 1Q Rev $273.7M; 05/04/2018 - Already more than 70 million square feet of retail space is slated to go dark in 2018, according to CoStar Group; 13/04/2018 - Investor Expectations to Drive Momentum within Criteo S.A, Prima BioMed, CoStar Group, DBV Technologies S.A, Hollysys Automatio

Abrams Capital Management Lp decreased its stake in Teva Pharmaceutical Inds Ltd (TEVA) by 2.57% based on its latest 2019Q1 regulatory filing with the SEC. Abrams Capital Management Lp sold 476,016 shares as the company’s stock declined 47.93% . The hedge fund held 18.05M shares of the major pharmaceuticals company at the end of 2019Q1, valued at $282.97M, down from 18.52M at the end of the previous reported quarter. Abrams Capital Management Lp who had been investing in Teva Pharmaceutical Inds Ltd for a number of months, seems to be less bullish one the $7.45 billion market cap company. The stock decreased 3.70% or $0.27 during the last trading session, reaching $7.02. About 19.92M shares traded. Teva Pharmaceutical Industries Limited (NYSE:TEVA) has declined 66.58% since August 11, 2018 and is downtrending. It has underperformed by 66.58% the S&P500. Some Historical TEVA News: 10/04/2018 - Mylan to Acquire the Global Marketing Rights to a Once-monthly Glatiramer Acetate Product through an Investment and Partnership with Israeli Company Mapi Pharma; 14/05/2018 - Advair ( fluticasone propionate + salmeterol ; GlaxoSmithKline) Drug Overview 2018: A Fixed-Dose Combination of an lnhaled Corticosteroid and a Long-Acting Beta 2 Agonist - ResearchAndMarkets.com; 26/03/2018 - VANDA GOT PARAGRAPH IV NOTE ON TEVA ANDA ON HETLIOZ GENERIC; 23/05/2018 - Teva hopes to launch migraine drug as soon as September; 03/04/2018 - KC Bus Journal: Teva sells OP business segment; 29/03/2018 - AstraZeneca’s Symbicort ( budesonide + formoterol ) Drug Analysis Report 2018 - ResearchAndMarkets.com; 15/04/2018 - TEVA: HISTADRUT WARNS CO. AGAINST CLOSURE OF ASHDOD FACTORY; 24/05/2018 - AMARIN - TEVA MAY FIRST BEGIN SELLING ITS GENERIC VERSION OF VASCEPA IN U.S. ON AUGUST 9, 2029, OR EARLIER UNDER CERTAIN CUSTOMARY CIRCUMSTANCES; 21/04/2018 - Mylan Presents Equivalence Data on Glatiramer Acetate Compared to Copaxone® at American Academy of Neurology 70th Annual Meeting; 13/03/2018 - TEVA CFO MICHAEL MCCLELLAN SPEAKS AT ANALYST CONFERENCE

Investors sentiment increased to 1.35 in Q1 2019. Its up 0.52, from 0.83 in 2018Q4. It improved, as 14 investors sold CSGP shares while 113 reduced holdings. 66 funds opened positions while 106 raised stakes. 33.52 million shares or 0.12% less from 33.56 million shares in 2018Q4 were reported. Michigan-based Comerica Bancorp has invested 0.02% in CoStar Group, Inc. (NASDAQ:CSGP). Metropolitan Life Insur owns 3,389 shares or 0% of their US portfolio. Sands Cap Mngmt Lc accumulated 2.16% or 1.50M shares. 4,709 were reported by Stephens Ar. Zeke Cap Ltd Liability Corporation invested 0.07% of its portfolio in CoStar Group, Inc. (NASDAQ:CSGP). Raymond James Assoc holds 0.01% of its portfolio in CoStar Group, Inc. (NASDAQ:CSGP) for 8,778 shares. Charles Schwab Invest Mngmt owns 111,322 shares. Alliancebernstein Ltd Partnership invested 0.05% in CoStar Group, Inc. (NASDAQ:CSGP). Dekabank Deutsche Girozentrale has 1,997 shares for 0.01% of their portfolio. Morgan Stanley reported 0.01% in CoStar Group, Inc. (NASDAQ:CSGP). Art Advisors Ltd Co reported 4,220 shares stake. Tocqueville Asset Mngmt Ltd Partnership holds 2,205 shares or 0.01% of its portfolio. Balyasny Asset Lc holds 0.2% or 64,221 shares in its portfolio. British Columbia - Canada-based British Columbia Management has invested 0.06% in CoStar Group, Inc. (NASDAQ:CSGP). Columbus Circle reported 87,744 shares or 1.04% of all its holdings.

Analysts await CoStar Group, Inc. (NASDAQ:CSGP) to report earnings on October, 22. They expect $2.24 earnings per share, up 13.13% or $0.26 from last year’s $1.98 per share. CSGP’s profit will be $81.87M for 70.73 P/E if the $2.24 EPS becomes a reality. After $1.95 actual earnings per share reported by CoStar Group, Inc. for the previous quarter, Wall Street now forecasts 14.87% EPS growth.

More notable recent CoStar Group, Inc. (NASDAQ:CSGP) news were published by: Seekingalpha.com which released: “CoStar Group rallies 11.3% post Q4 results - Seeking Alpha” on February 27, 2019, also Finance.Yahoo.com with their article: “Ron Baron Comments on CoStar Group - Yahoo Finance” published on April 29, 2019, Business.Financialpost.com published: “CoStar Signs Agreement with The Behar Group Realty, Inc. - Financial Post” on July 15, 2019. More interesting news about CoStar Group, Inc. (NASDAQ:CSGP) were released by: Bizjournals.com and their article: “CoStar posts record earnings - Washington - Washington Business Journal” published on October 25, 2018 as well as Finance.Yahoo.com‘s news article titled: “Should CoStar Group, Inc. (NASDAQ:CSGP) Focus On Improving This Fundamental Metric? - Yahoo Finance” with publication date: May 07, 2019.

More notable recent Teva Pharmaceutical Industries Limited (NYSE:TEVA) news were published by: Finance.Yahoo.com which released: “Bronstein, Gewirtz & Grossman, LLC Class Action Reminder - BUD, TEVA & HSDT - Yahoo Finance” on August 09, 2019, also Globenewswire.com with their article: “CLASS ACTION UPDATE for BUD, TEVA, EQT and INS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders - GlobeNewswire” published on July 16, 2019, Globenewswire.com published: “SHAREHOLDER ALERT: TEVA DBD OMCL NFLX: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines - GlobeNewswire” on July 30, 2019. More interesting news about Teva Pharmaceutical Industries Limited (NYSE:TEVA) were released by: Benzinga.com and their article: “Teva Pharmaceutical Q2 Earnings Preview - Benzinga” published on August 06, 2019 as well as Benzinga.com‘s news article titled: “Large Option Trader Makes Aggressive Bearish Play On Teva - Benzinga” with publication date: July 22, 2019.

CoStar Group, Inc. (NASDAQ:CSGP) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.